FindTrial
Sign In

Development of Disease Activity Index for Celiac Disease

Derivation and Validation of a classification system for defining Response and Remission to Gluten-free diet in patients with Celiac Disease - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099966
Enrollment
100
Registered
2025-12-30
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K318- Other specified diseases of stomach and duodenum

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

University Grants Commission
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Celiac disease on a Gluten-free Diet 1. Patients with celiac disease as defined by positive Celiac Serology and proven by small intestinal mucosal biopsy: Diagnosis of CeD to be based on the combination of clinical manifestations, positive IgA anti-tTG antibody, and a deep duodenal biopsy demonstrating the presence of villous abnormalities of at least Marsh grade 2 (ICMR Guideline on Diagnosis and Management of Celiac Disease) [10] 2. Age: 18 to 60 years 3. Gender: Both male and female patients with CeD

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study 2. Patients with chronic illness (Cancer/Chronic Kidney Disease) 3. Pregnant or lactating mothers

Design outcomes

Primary

MeasureTime frame
Disease Activity IndexTimepoint: Baseline, 3 months, 6 months, 12 months—

Secondary

MeasureTime frame
Response to Gluten-free diet scoreTimepoint: 6 months 1 year—

Countries

India

Contacts

Public ContactGovind K Makharia

All India Institute of Medical Sciences, New Delhi

govindmakharia@gmail.com9910678476

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026